Predictors of Participation in Prenatal Substance Use Assessment, Counseling, and Treatment Among Pregnant Individuals in Prenatal Settings Who Use Cannabis DOI Creative Commons
Gwen T. Lapham, W. Felicia, Kelly C. Young‐Wolff

et al.

Journal of Addiction Medicine, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 15, 2024

Objectives Assessment and counseling are recommended for individuals with prenatal cannabis use. We examined characteristics that predict substance use assessment among who screened positive in settings. Methods Electronic health record data from Kaiser Permanente Northern California’s Early Start perinatal screening, assessment, program was used to identify ≥1 pregnancies Outcomes included completion of a those assessed, attendance only or Addiction Medicine Recovery Services (AMRS) treatment. Predictors demographics past-year psychiatric disorder diagnoses evaluated GEE multinomial logistic regression. Results The sample 17,782 20,398 (1/2011–12/2021). Most (80.3%) had an assessment. Individuals Medicaid, anxiety, depression tobacco disorders, compared without, higher odds greater parity, older age (≥35) later trimesters, lower Among 64% (n = 10,469) needing intervention based on most (88%) attended AMRS (with without Start). Greater parity trimester associated odds, while Medicaid counseling. Nearly all diagnosed disorders were Conclusions A comprehensive engaged pregnant Opportunities improve care gaps remain.

Language: Английский

Sex disparities in outcome of medication-assisted therapy of opioid use disorder: Nationally representative outpatient clinic data DOI
Eduardo R. Butelman, Yuefeng Huang,

A.H. Mcfarlane

et al.

Drug and Alcohol Dependence, Journal Year: 2025, Volume and Issue: 267, P. 112535 - 112535

Published: Jan. 5, 2025

Language: Английский

Citations

2
Cannabinoids and the Gastrointestinal Tract DOI Creative Commons
Michael Camilleri, Ting Zheng

Clinical Gastroenterology and Hepatology, Journal Year: 2023, Volume and Issue: 21(13), P. 3217 - 3229

Published: Sept. 9, 2023

Language: Английский

Citations

14
Substance Use Treatment Completion Among Unhoused Young Adults: A Predictive Modeling Approach DOI
Nathaniel A. Dell, Charvonne Long, Christopher P. Salas‐Wright

et al.

Journal of Drug Issues, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 19, 2024

Background: Unhoused young adults aged 18–24 years are at increased risk of substance misuse relative to the general population and experience unique barriers engaging in treatment. This study evaluates predictors treatment completion for unhoused receiving use Methods: Predictive models were generated on data from 2020 Treatment Episode Data Set-Discharges. The sample included discharges involving ( N = 12,273). Model performance was assessed by inspecting several evaluative metrics. Results: Overall, each model performed relatively well (AUC: 0.7234–0.7753). Classification trained balanced predicted a higher proportion completers. Models also achieved accuracy F1 scores imbalanced data. Conclusions: Findings reveal multiple features important accurate classification completion, which may be useful developing individualized interventions support clients’ engagement services.

Language: Английский

Citations

1
Sex disparities in outcome of medication-assisted therapy of opioid use disorder: Nationally representative study DOI Creative Commons
Eduardo R. Butelman, Yuefeng Huang,

A.H. Mcfarlane

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 26, 2024

Abstract Question The opioid epidemic causes massive morbidity, and males have substantially greater overdose mortality rates than females. It is unclear whether there are sex-related disparities at different stages in the trajectory of use disorders, “real world” settings. Goal To determine sex non-medical (NMOU) end outpatient medication-assisted treatment (MAT), using nationally representative data. Design Observational epidemiological study publicly funded MAT programs national “Treatment episode data set-discharges” (TEDS-D) for 2019. Participants Persons aged ≥18 their first episode, heroin or other opioids (N=11,549). binary outcome was presence/absence NMOU. Results In univariate analyses, had significantly higher odds NMOU, compared to females (odds ratio=1.27; Chi 2 [df:1]=39.08; uncorrected p<0.0001; p=0.0041 after Bonferroni correction). A multivariable logistic regression detected a male>female ratio 1.19 (95%CI=1.09-1.29; p<0.0001), adjusting socio-demographic/clinical variables. Several specific conditions were revealed which NMOU (e.g., ages 18-29 30-39; corrected p=0.012, if they used by inhalation; p=0.0041). Conclusions This indicates that MAT, indicating more unfavorable outcomes. reveals socio-demographic clinical variables under this disparity most prominent. Highlights * outcomes therapy large-scale study, adult month prior discharge from females, Males risk undesirable several younger age categories, route inhalation. Sex occur can be examined potentially addressed, with goal improving personalized approaches OUD.

Language: Английский

Citations

0
Trends and variations in admissions for cannabis use disorder among pregnant women in United States DOI
Maria C. Mejia de Grubb, Lea Sacca, Allison Ferris

et al.

Journal of Perinatal Medicine, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 24, 2024

Abstract Objectives Cannabis use disorder (CUD) among pregnant women is increasing, yet limited information exists on admissions for treatment in this population. This study examined trends CUD publicly funded U.S. facilities from 2000 to 2021. Methods Using the Treatment Episode Data Set-Admissions, we analyzed 33,729 of with CUD. Descriptive statistics were used assess patterns by race/ethnicity, age, and co-substance use. Results increased 2.7-fold, 2.3 % 6.2 2009, followed a decrease 4.3 2014, peak 6.7 2018, decline 3.0 In 2021, racial/ethnic disparities noted, higher proportions White (48.8 %) Black (32.5 non-Hispanic compared Hispanic (9.6 %). Admissions decreased aged ≤20 years old (y/o), but ≥30 y/o 2010 highest prevalence those 21–29 y/o. Co-substance use, particularly narcotics, stimulants, depressants, hallucinogens, was prevalent 2017 Conclusions have fluctuated over two decades, variations race/ethnicity age. These findings highlight need tailored interventions ongoing adaptation services

Language: Английский

Citations

0
Predictors of Participation in Prenatal Substance Use Assessment, Counseling, and Treatment Among Pregnant Individuals in Prenatal Settings Who Use Cannabis DOI Creative Commons
Gwen T. Lapham, W. Felicia, Kelly C. Young‐Wolff

et al.

Journal of Addiction Medicine, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 15, 2024

Objectives Assessment and counseling are recommended for individuals with prenatal cannabis use. We examined characteristics that predict substance use assessment among who screened positive in settings. Methods Electronic health record data from Kaiser Permanente Northern California’s Early Start perinatal screening, assessment, program was used to identify ≥1 pregnancies Outcomes included completion of a those assessed, attendance only or Addiction Medicine Recovery Services (AMRS) treatment. Predictors demographics past-year psychiatric disorder diagnoses evaluated GEE multinomial logistic regression. Results The sample 17,782 20,398 (1/2011–12/2021). Most (80.3%) had an assessment. Individuals Medicaid, anxiety, depression tobacco disorders, compared without, higher odds greater parity, older age (≥35) later trimesters, lower Among 64% (n = 10,469) needing intervention based on most (88%) attended AMRS (with without Start). Greater parity trimester associated odds, while Medicaid counseling. Nearly all diagnosed disorders were Conclusions A comprehensive engaged pregnant Opportunities improve care gaps remain.

Language: Английский

Citations

0